EGFR and hepatocellular carcinoma: Mechanistically, hCAP18/LL-37 promotes the release of HB-EGF, upregulates the phosphorylation of EGFR/HER2, activates the PI3K/Akt signaling pathway, and promotes HCC cells proliferation and tumor growth.